4π Noncoplanar Stereotactic Body Radiation Therapy for Head-and-Neck Cancer: Potential to Improve Tumor Control and Late Toxicity

4π plans may allow dose escalation with significant and consistent improvements in critical organ sparing, tumor control, and coverage.